Sunifiram
CAS: 314728-85-3
MF: C14H18N2O2
EINECS No. : 1312995-182-4
MF: C14H18N2O2
EINECS No. : 1312995-182-4
API376
Quantity
Sunifiram is a novel pyrrolidone nootropic drug that was developed by the Gualtieri research group in 2000.
Sunifiram was originally developed to treat neurodegenerative disorders, such as Alzheimer's disease.
Compared to piracetam, its anti-amnesiac activity is several orders of magnitude higher on a per-weight basis.
The drugs can be helpful in the treatment of neurodegenerative disorders like Alzheimer’s, Parkinson’s,
multiple sclerosis, schizophrenia, and attention-deficit hyperactivity disorders.
Sunifiram is a potent nootropic agent that provides a range of cognitive benefits.
Its ability to improve concentration, focus, and mental clarity can greatly aid in the management and completion of cognitive tasks.
In addition, it has been shown to enhance motivation, which is essential for achieving cognitive goals.
